Results 171 to 180 of about 70,747 (277)

Subgroups of the BENEFIT study: Risk of developing MS and treatment effect of interferon beta-1b

, 2007
CH Polman, Ludwig Kappos, Mark S. Freedman, Gilles Edan, H-P Hartung, David H. Miller, Xavier Montalbán, Frederik Barkhof, Krzysztof Selmaj, Bernard M.J. Uitdehaag, S. Dahms, Lars Bauer, Christoph Pohl, Rupert Sandbrink, for the BENEFIT investigators**   +14 more
openalex   +2 more sources

A long-term follow-up study on biochemical and clinical biomarkers of response to interferon beta-1b treatment in relapsing-remitting multiple sclerosis

, 2020
Anna Pietrzak, Alicja Kalinowska, Krystyna Osztynowicz, A Khamidulla, Wojciech Kozubski, S. Michalak   +5 more
openalex   +1 more source

Effect of arginine on pre-nucleus stage of interferon beta-1b aggregation. [PDF]

AAPS PharmSciTech, 2014
Fazeli A, Haji-Abdolvahab M, Shojaosadati SA, Schellekens H, Khalifeh K, Moosavi-Movahedi AA, Fazeli MR.   +6 more
europepmc   +1 more source

Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b) [PDF]

, 1998
Ferdinando Nicoletti, Roberto Di Marco, Francesco Patti, E. Reggio, Alessandra Nicoletti, Paola Zaccone, Franca Stivala, Pier Luigi Meroni, A. Reggio   +8 more
openalex   +1 more source

Quantification and characterization of anti-interferon beta antibodies in multiple sclerosis patients undergoing interferon beta-1b therapy

, 2009
Ebrima Gibbs
openalex   +1 more source

The Role of miRNAs in Chicken Immune Regulation and Prospects for Disease‐Resistant Breeding

Animal Research and One Health, EarlyView.
A schematic workflow illustrating the screening of disease‐resistant miRNAs and the generation of miRNA‐based disease‐resistant chickens via PGC‐mediated germline genome editing. ABSTRACT MicroRNAs (miRNAs) are emerging as pivotal regulators of the immune system, playing a decisive role in shaping disease resistance in chicken.
Qiangzhou Wang, Weiran Wu, Qingqing Cai, Jiaxing Wang, Qi Gao, Muhammad Iftikhar, Yulin Bi, Hao Bai, Lihong Gu, Guobin Chang, Shihao Chen   +10 more
wiley   +1 more source

Predictors of disease activity in 857 patients with MS treated with interferon beta-1b. [PDF]

J Neurol, 2015
Hartung HP, Kappos L, Goodin DS, O'Connor P, Filippi M, Arnason B, Comi G, Cook S, Jeffery D, Petkau J, White R, Bogumil T, Beckmann K, Stemper B, Suarez G, Sandbrink R, Pohl C.   +16 more
europepmc   +1 more source

Cytokine Pathways Driving Diverse Tissue Pathologies in Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Rheumatoid arthritis (RA) is a complex systemic disorder characterized primarily by articular inflammation and destruction with associated functional loss and reduced quality of life. RA is also associated with extra‐articular disease, such as that of the lung, with potentially devastating clinical consequences. The critical importance of comorbidities,
Aurelie Najm, Lyn D. Ferguson, Iain B. McInnes   +2 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Survey of US Patients with Multiple Sclerosis: Comparison of the New Electronic Interferon Beta-1b Autoinjector (BETACONNECT™) With Mechanical Autoinjectors. [PDF]

Neurol Ther, 2016
Barone DA, Singer BA, Merkov L, Rametta M, Suarez G.   +4 more
europepmc   +1 more source